Feed

Show only
12 September 2017
CMS part­ners with Saudi Ar­a­bi­an law firm
07 Nov 17
Save the Date: Dy­nam­ic Mar­kets and Vir­tu­al Risks
CMS Glob­al Lifes­ci­ences For­um 2017
20/09/2017
Pub­lic Coun­try-by-Coun­try Re­port­ing; Tax­pay­er­s' Rights
Ap­pro­pri­ate Use of Coun­try-by-Coun­try Re­ports The OECD has now pub­lished Guid­ance (avail­able here) on the ap­pro­pri­ate use of Coun­try-by-Coun­try Re­ports (‘Cb­CRs’) by na­tion­al tax au­thor­it­ies. This is in re­sponse to some val­id MNE con­cerns that tax au­thor­it­ies.
06/09/2017
CMS On your radar - Septem­ber 2017
Key em­ploy­ment is­sues world­wide
14/09/2017
EU-US Pri­vacy Shield un­der High Scru­tiny
On 18 Septem­ber 2017, US Sec­ret­ary of Com­merce Wil­bur Ross and European Com­mis­sion­er Vĕra Jour­ova will launch the first an­nu­al re­view of the EU-US Pri­vacy Shield agree­ment (“Pri­vacy Shield”). The re­view will be a two-day ex­er­cise where European Com­mis­sion rep­res­ent­at­ives.
1 September 2017
CEE Pub­lic Pro­cure­ment Tool­box for Rem­ed­ies
13/09/2017
The ap­plic­a­tion of EU mer­ger con­trol cla­ri­fied: no EC no­ti­fic­a­tion...
In the first ever pre­lim­in­ary rul­ing on the EU mer­ger con­trol re­gime, the Court of Justice of the European Uni­on ("CJEU") brought much needed clar­ity on wheth­er the shift from sole con­trol to joint con­trol in an ex­ist­ing un­der­tak­ing is covered by the EU Mer­ger.
31/08/2017
The cur­rent state of the char­ging in­fra­struc­ture in...
20/09/2017
CMS wel­comes new mem­bers of the Real Es­tate Team in Par­is. A team...
07/09/2017
In­tel: no sub­sti­tute for ana­lys­is: Court re­news fo­cus on likely harm...
The long-awaited In­tel judg­ment on re­bates, re­leased on 6 Septem­ber, has es­tab­lished, fol­low­ing years of de­bate, a stand­ard for reg­u­lat­ory in­ter­ven­tion that re­quires a fo­cus on the likely ef­fects of in­di­vidu­al re­bate schemes in their par­tic­u­lar con­text.
Dimitar Zwiatkow
31/08/2017
The changes to the “Best Avail­able Tech­niques Ref­er­ence...
20/09/2017
EXPO REAL 2017 will be host­ing Dr. Dirk Rode­woldt and he will be speak­ing...
30/08/2017
The leg­al and reg­u­lat­ory chal­lenges of get­ting a bi­osim­il­ar product...
After a pharma view on bi­osim­il­ars was provided in the pre­vi­ous Ex­pert View column, a leg­al per­spect­ive is provided by Nick Beck­ett, man­aging part­ner at CMS Beijing and glob­al co-head of the firm­'s lifes­ci­ences sec­tor group.
22 August 2017
Green­field In­vest­ments in CEE 2017